Abstract
In transplantation, organs, cells, or tissue is harvested from one individual and grafted into another individual. The transplant could be autologous, where the transplanted graft is from the same individual or it could be allogeneic, where the graft is transplanted in a genetically different individual. In this chapter, the focus is predominantly on allogeneic transplantation. The ability to distinguish self from nonself resides in the HLA molecules, which are identified for the purpose of tissue typing to find a compatible donor when necessary. Recognition of grafted tissue as self or nonself is the result of inheritance of codominant genes. The mechanism of rejection involves both the innate and acquired immune responses, and various cell types and molecules particularly T cells, NK cells, adhesion molecules, and antibodies have roles in these processes. This forms a significant part of the discussion. Lastly, transplantation of individual tissue and cell types including the kidney, liver, pancreas, heart, lung, hematopoietic stem cells, and bone marrow is described. There is discussion of graft-versus-host disease and ways to minimize the rejection process.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Bibliography
Abt P, Shaked A (2003) The allograft immune response. Graft 6:71–79
Alegre ML, Najafian N (2006) Costimulatory molecules as targets for the induction of transplantation tolerance. Curr Mol Med 6:843–857
Alexander T, Bondanza A, Muraro PA, Greco R et al (2015) SCT for severe autoimmune diseases: consensus guidelines of the European society for blood and marrow transplantation for immune monitoring and bio banking. Bone Marrow Transplant 50:173–180
Antin JH, Ferrara JL (1992) Cytokine dysregulation and acute graft vs host disease. Blood 80:2964–2968
Arkelov A, Lakkis FG (2000) The alloimmune response and effector mechanisms of allograft rejection. Semin Nephrol 20:95–102
Azuma H, Tilney NL (1995) Immune and nonimmune mechanisms of chronic rejection of kidney allografts. J Heat Lung Transplant 14:S136–S142
Bellgrau D, Gold D, Selawry H, Moore J et al (1995) A role for CD95 ligand in preventing graft rejection. Nature 377:630–632
Benichou G, Fedoseyeva EV (1996) The contribution of peptides to T cell allorecognition and allograft rejection. Int Rev Immunol 13:231–243
Benjamin LC, Allan JS, Madsen JC (2002) Cytokines in immunity and allograft rejection. Crit Rev Immunol 22:269–279
Betkowski AS, Graff R, Chen JJ, Hauptman PJ (2002) Panel- reactive antibody screening practices prior to heart transplantation. J Heart Lung Transplant 21:644–650
Billingham RE (1966) The biology of graft-versus-host reactions. Harvey Lect 67:21–78
Bishop DK, Shelby J, Eichwald EJ (1992) Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4- positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration and acute allograft rejection. Transplantation 53:849–857
Bishop DK, Li W, Chan SY, Ensley RD et al (1994) Helper T lymphocytes unresponsiveness to cardiac allografts following transient depletion of CD4-positive cells. Implications for cellular and humoral responses. Transplantation 58:576–584
Brent L (1997) History of transplantation immunology. Academic, San Diego
Broelsch CE, Burdelski M, Rogiers X, Gundlach M et al (1994) Living donor for liver transplantation. Hepatology 20:49S–55S
Bromberg JS, Murphy B (2001) Routes to allograft survival. J Clin Invest 107:797–798
Brook NR, Nicholson ML (2003) Kidney transplantation from non-heart-beating donors. Surgeon 1:311–322
Bucin D (1988) Blood transfusion in renal transplantation – the induction of tolerance by incompatibility for class I antigen. Med Hypothesis 27:19–27
Burt RK, Oyama Y, Verda L, Quigley K et al (2004) Induction of remission of severe and refractory rheumatoid arthritis by allogeneic mixed chimerism. Arthritis Rheum 50:2466–2470
Burt RK, Loh Y, Pearce W, Boehar N et al (2008) Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. JAMA 299:925–936
Chalasani G, Li Q, Konieczny BT, Smith-Diggs L et al (2004) The allograft defines the type of rejection (acute vs chronic) in the face of an established effector immune response. J Immunol 172:7813–7820
Codarri L, Vallotton L, Ciuffreda D, Venetz JP et al (2007) Expansion and tissue infiltration of an allospecific CD4+CD25+CD45RO+IL-7R (alpha) high cell population in solid organ transplant recipients. J Exp Med 204:1533–1541
Cooper DK (1969) Transplantation of the heart and both lungs. I. Historical review. Thorax 24:383–390
Doyle AM, Lechler RI, Turka LA (2004) Organ transplantation: half-way through the first century. J Am Soc Nephrol 15:2965–2971
Dreger P, Kloss M, Petersen B, Haferlach T et al (1995) Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts. Blood 86:3970–3978
El-Asady RS, Rongwen Y, Hadley GA (2003) The role of CD103 ([alpha]E[beta] 7 integrin) and other adhesion molecules in lymphocyte migration to organ allografts: mechanisms of rejection. Curr Opin Organ Transplant 8:1–6
El-Sawy T, Miura M, Fairchild R (2004) Early T cell response to allografts occurring prior to alloantigen priming up-regulates innate-mediated inflammation and graft necrosis. Am J Pathol 165:147–157
El-Sawy T, Belperio JA, Strieter RM, Remick DG et al (2005) Inhibition of polymorphonuclear leukocyte-mediated graft damage synergizes with short-term costimulatory blockade to prevent cardiac allograft rejection. Circulation 112:320–331
Ferrara JL, Deeg HJ (1991) Graft-versus-host disease. NEJM 324:667–674
Ferrara JLM, Cooke KR, Pan L, Krenger W (1996) The immunopathophysiology of acute graft-versus-host-disease. Stem Cells 14:473–489
Field EH, Matesic D, Rigby S, Fehr T et al (2001) CD4+CD25+ regulatory cells in acquired MHC tolerance. Immunol Rev 182:99–112
Flye MW (ed) (1989) Principles of organ transplantation. W. B. Saunders, Philadelphia
Galili U (1993) Interaction of the natural anti-Gal antibody with α-galactosyl epitopes: a major obstacle of xenotransplantation in humans. Immunol Today 14:480–482
Game DS, Lechler RI (2002) Pathways of allorecognition: implications for transplantation tolerance. Transpl Immunol 10:101–108
Gebel HM, Bray RA (2000) Sensitization and sensitivity: defining the unsensitized patients. Transplantation 69:1370–1374
Goulmy E, Schipper R, Pool J, Blokland E et al (1996) Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host-disease after bone marrow transplantation. NEJM 334:281–285
Griepp RB, Ergin MA (1984) The history of experimental heart transplantation. J Heart Transplant 3:145–145
Griffith BP, Hardesty RL, Trento A, Bahnson HT (1985) Asynchronous rejection of heart and lungs following cardiopulmonary transplantation. Ann Thorac Surg 40:488–493
Griffith TS, Brunner T, Fletcher SM, Green DR et al (1995) Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270:11889–1192
Hakim NS (2003) Recent developments and future prospects in pancreatic transplantation. Exp Clin Transplant 1:26–34
Hall B, Jelbart ME, Gurley KE, Dorsch SE (1990) Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of CD4+ suppressor cell and its mechanisms of action. J Exp Med 171:141–157
Hall BM, Chen J, Robinson C, Xy H et al (2002) Therapy with mab to CD25 blocks function of CD4 + CD25+ T regulatory cells which maintain transplantation tolerance. Nephrology 7:A111–A111
Hayry P (1996) Pathophysiology of chronic rejection. Trans Proc 28:7–10
Hayry P, Isoniemi H, Yilmaz A, Mennander K et al (1993) Chronic allograft rejection. Immunol Rev 134:33–81
Iwasaki A, Medzhitov R (2010) Regulation of adaptive immunity by the innate immune system. Science 327:291–295
Kahan BD (1991) Transplantation timeline. Mankind’s three millennia-one maverick’s three decades in the struggle against biochemical individuality. Transplantation 51:1–21
Kang SM, Tang Q, Bluestone JA (2007) CD4+CD25+ regulatory T cells in transplantation: progress, challenges and prospects. Am J Transplant 7:1457–1463
Kaufman DB, Koffron A (2006) Pancreas transplantation. www.emedicine.com/med/topic2605.htm
Kerman RH, Orosz CG, Lorber MI (1997) Clinical relevance of anti-HLA antibodies pre and post-transplant. Am J Med Sci 313:275–278
Kitchens WH, Uehara S, Chase CM, Coluin RB et al (2006) The changing role of natural killer cells in solid organ rejection and tolerance. Transplantation 81:811–817
Klein J (1986) Natural history of the major histocompatibility complex. Wiley, New York
Krensky AM (2004) Immunologic tolerance. Pediatr Nephrol 16:675–679
Krensky AM, Clayberger C (2004) Prospects for induction of tolerance in renal transplantation. Pediatr Nephrol 8:772–779
Krieger NR, Yin DP, Fathman CG (1996) CD4+ but not CD8+ cells are essential for allorejection. J Exp Med 184:2013–2018
LaRosa DF, Rahman AH, Turka LA (2007) The innate immune system in allograft rejection and tolerance. J Immunol 178:7503–7509
Lattmann T, Hein M, Horber S, Ortmann J et al (2005) Activation of pro-inflammatory and anti-inflammatory cytokines in host organs during chronic allograft rejection: role of endothelin receptor signaling. Am J Transplant 5:1042–1049
Lau HT, Yu M, Fontana A, Stoeckert CJ (1996) Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science 273:109–112
Lau CL, Palmer SM, Posther KE, Howell DN et al (2000) Influence of panel-reactive antibodies on post-transplant outcomes in lung transplant recipients. Ann Thorac Surg 69:1520–1524
Majno G (1975) The healing hand. Man and wound in the ancient world. Harvard University Press, Cambridge, MA
Mancini MC (2006) Heart-lung transplantation. www.emedicine.com/med/topic2063.htm
Mancini MC, Gangahar DM (2006) Heart transplantation. www.emedicine.com/med/topic3187.htm
Mandanas RA (2006) Graft vs. host disease. www.emedicine.com/medtopic926.htm
Manes TD, Pober JS (2008) Antigen presentation by human microvascular endothelial cells triggers ICAM-1-dependent transendothelial protrusion by, and fractalkine-dependent transendothelial migration of, effector memory CD4+ T cells. J Immunol 180:8386–8392
Manzarbeitia C (2006) Liver transplantation. www.emedicine.com/med/topic3510.htm
Matthews LG (1968) S.S. Cosmas and Damian – Patron Saints of medicine and pharmacy. Their cult in England. Med Hist 12:281–288
Medawar PB (1986) Memoir of a thinking radish. Oxford University Press, Oxford
Merrill JP, Murray JE, Harrison JH, Guild WR (1984) Landmark article Jan. 28, 1956. Successful homotransplantation of the human kidney between identical twins. JAMA 251:2566–2571
Morris PJ (2004) Transplantation – a medical miracle of the 20th century. NEJM 351:2678–2680
Muraro PA, Robins H, Malhotra S, Howell M et al (2014) T cell repertoire following autologous stem cell transplantation for multiple sclerosis. J Clin Invest 124:1168–1172
Murphy B, Krensky AM (1999) HLA-derived peptides as novel immunomodulatory therapeutics. J Am Soc Nephrol 10:1346–1355
Nash RA, McSweeney PA, Nelson JL, Werner M et al (2006) Allogeneic marrow transplantation in patients with severe systemic sclerosis: resolution of dermal fibrosis. Arthritis Rheum 54:1982–1986
Norman DJ (1998) Expected clinical outcomes/risk factors. In: Norman DJ, Suke WN (eds) Primer on transplantation. American Society of Transplant Physicians, Thorofare, pp 245–250
Oberbarnscheidt MH, Zeng Q, Li Q, Dai H et al (2014) Non-self recognition by monocytes initiates allograft rejection. J Clin Invest 124:3579–3589
Oryoji K, Himeji D, Nagafuji K, Horiuchi T et al (2005) Successful treatment of rapidly progressive interstitial pneumonia with autologous peripheral blood stem cell transplantation in a patient with dermatomyositis. Clin Rheumatol 24:637–640
Paul LC (1995) Immunobiology of chronic renal transplant rejection. Blood Purif 13:206–218
Petersdorf EW, Hansen JA, Martin PJ, Woolfrey A et al (2001) Major-histocompatibility-complex class I alleles and antigens in hematopoietic cell transplantation. NEJM 345:1794–1800
Philip T, Gugliemli C, Hagenbeek A, Somers R et al (1995) Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin’s lymphoma. NEJM 333:1540–1545
Pinderski LJ, Kirklin JK, McGiffin D, Brown R et al (2005) Multi-organ transplantation: is there a protective effect against acute and chronic rejection? J Heart Lung Transplant 24:1828–1833
Prescilla RP, Mattoo TK (2006) Immunology of transplant rejection. www.emedicine.com/ped/topic2841.htm
Rana RE, Arora BS (2002) History of plastic surgery in India. J Postgrad Med 48:76–78
Reitz BA, Wallwork JL, Hunt SA, Pennock JL et al (1982) Heart-lunch transplantation: successful therapy for patients with pulmonary vascular disease. NEJM 306:557–564
Rocha PN, Plumb TJ, Crowley SD, Coffman TM (2003) Effector mechanisms in transplant rejection. Immunol Rev 196:51–64
Roopenian D, Choi EY, Brown A (2002) The immunogenomics of minor histocompatibility antigens. Immunol Rev 190:86–94
Rosen O, Thiel A, Massenkeil G, Hiepe F et al (2000) Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells. Arthritis Res 2:327–336
Rosenberg AS, Singer A (1992) Cellular basis of skin allograft rejection: an in vivo model of immune-mediated tissue destruction. Ann Rev Immunol 10:333–358
Rossini AA, Greiner DL, Mordes JP (1999) Induction of immunologic tolerance for transplantation. Physiol Rev 79:99–41
Roush W (1995) Xenotransplantation. New ways to avoid organ rejection and buoy hopes. Science 270:234–235
Rubinstein P (2001) HLA matching for bone marrow transplantation – how much is enough? NEJM 345:1842–1844
Ruiz P, Sarwar S, Suterwala MS (2006) Graft versus host disease. www.emedicinecom/ped/topic893.htm
Sablinski T, Sayegh MH, Hancock WW, Kut JP et al (1991) Differential role of CD4+ cells in the sensitization and effector phases of accelerated graft rejection. Transplantation 51:226–231
Sade RM (2005) Transplantation at 100 years: Alexis Carrel, pioneer surgeon. Ann Thorac Surg 80:2415–2418
Sakaguchi S (2006) Regulatory T cells: Meden again. Immunol Rev 212:1–5
Sakaguchi S, Ono M, Setoguchi R, Yagi H et al (2006) Foxp3+CD25+Cd4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 212:8–27
Salvalaggio PRO, Camirand G, Ariyan CD, Deng S et al (2006) Antigen exposure during enhanced CTLA-4 expression promotes allograft tolerance in vivo. J Immunol 176:2292–2298
Sanfilippo F (1998) Transplantation tolerance – the search continues. NEJM 339:1700–1702
Sayegh MH, Carpenter CB (1996) Role of indirect allorecognition in allograft rejection. Int Rev Immunol 13:221–229
Sayegh MH, Carpenter CB (2004) Transplantation 50 years later – progress, challenges and promises. NEJM 351:2761–2766
Sayegh MH, Turka LA (1998) The role of T cell costimulatory activation pathways in transplant rejection. NEJM 338:1813–1821
Scheinfeld NS, Kuechle MK (2007) Graft versus host disease. www.emedicine.com/derm/toic478.htm
Schenk A, Nozaki T, Rabant M, Valujskikh A et al (2008) Donor-reactive CD8 memory T cells infiltrate cardiac allografts within 24 hours post-transplant in naïve recipients. Am J Transplant 8:1652–1661
Schenk AD, Gorbacheva V, Rabant M, Fairchild RL et al (2009) Effector functions of donor-reactive CD8 memory T cells are dependent on ICOS induced during division in cardiac grafts. Am J Transplant 9:64–73
Shapiro AMJ, Lakey JRT, Ryan EA (2000) Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. NEJM 343:230–238
Shlomchik WD (2007) Graft vs. host disease. Nat Rev Immunol 7:340–352
Sho M, Kishimoto K, Harada H, Livak M et al (2005) Requirements for induction and maintenance of peripheral tolerance in stringent allograft models. Proc Natl Acad Sci 102:13230–13235
Silverstein AM (1988) A history of immunology. Academic, San Diego
Socie G, Mary JY, Lemann M (2004) Prognostic value of apoptotic cells and infiltrating neutrophils in graft-versus-host disease of the gastrointestinal tract in humans: TNF and Fas expression. Blood 103:50–57
Spierings E, Vermeulen CJ, Vogt MH, Doerner LE et al (2003) Identification of HLA class II restricted H-Y-specific T-helper epitope evoking CD4+ T-helper cells in H-Y-mismatched transplantation. Lancet 362:610–615
Statkute L, Oyanna Y, Barr WG, Sufit R et al (2008) Autologous non-myeloablative haematopoietic stem cell transplantation for refractory systemic vasculitis. Ann Rheum Dis 67:991–997
Strom TB (2004) Is transplantation tolerable? J Clin Invest 113:1681–1683
Sullivan KM (1999) Graft-versus-host disease. In: Thomas ED (ed) Hematopoietic cell transplantation, 2nd edn. Blackwell Science, Boston
Sykes M (1996) Immunobiology of transplantation. FASEB J 10:721–730
Sykes M, Nikolic B (2005) Treatment of severe autoimmune disease by stem-cell transplantation. Nature 43:620–627
Tambur AR, Pamboukian SV, Costanzo MR, Herrera ND et al (2005) The presence of HLA-directed antibodies after heart transplantation is associated with poor allograft outcome. Transplantation 80:1019–1025
Terasaki PE (ed) (1991) A history of transplantation: thirty-five recollections. UCLA Tissue Typing Laboratory Press, Los Angeles
Thomas ED, Lochte HL Jr, Lu WC, Ferrebee JW (1957) Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. NEJM 257:491–496
Tilney NL (2000) Transplantation and its biology: from fantasy to routine. J Appl Physiol 89:1681–1689
Valujskikh A (2006) The challenge of inhibiting alloreactive T-cell memory. Am J Transplant 6:647–651
Valujskikh A, Lakkis FG (2003) In remembrance of things past: memory T cells and transplant rejection. Immunol Rev 196:65–74
Van Buskirk AM, Pidwell DJ, Adam PW, Orosz CG (1997) Transplantation immunology. JAMA 278:1993–1999
Van Twuyver E, Mooijaart RJ, tenBerge IJ, Van der Horst AR et al (1991) Pretransplantation blood transfusion revisited. NEJM 325:1210–1213
Walch JM, Zeng Q, Li Q, Oberbarnscheidt MH et al (2013) Cognate antigen directs CD8+ T cell migration to vascularized transplant. J Clin Invest 123:2663–2671
Yang N, Wernig M (2013) Harnessing the stem cell potential: a case for neural stem cell therapy. Nat Med 19:1580–1581
Zhang Q, Chen Y, Fairchild RL, Heeger PS et al (2006) Lymphoid sequestration of alloreactive memory CD4 T cells promotes cardiac allograft survival. J Immunol 176:770–777
Zheng XX, Markees TG, Hancock WW, Li Y et al (1999) CTLA4 signals are required to optimally induce allograft tolerance with combined donor specific transfusion and anti-CD154 monoclonal antibody treatment. J Immunol 162:4983–4990
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Khan, M.M. (2016). Tissue Transplantation. In: Immunopharmacology. Springer, Cham. https://doi.org/10.1007/978-3-319-30273-7_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-30273-7_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-30272-0
Online ISBN: 978-3-319-30273-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)